Moraes-Vieira et al., 2010 - Google Patents
Differential monocyte STAT6 activation and CD4+ CD25+ Foxp3+ T cells in kidney operational tolerance transplanted individualsMoraes-Vieira et al., 2010
View PDF- Document ID
- 1643620842538793261
- Author
- Moraes-Vieira P
- Silva H
- Takenaka M
- Monteiro S
- Lemos F
- Saitovitch D
- Kalil J
- Coelho V
- Publication year
- Publication venue
- Human immunology
External Links
Snippet
In organ transplantation, the immunosuppression withdrawal leads, in most cases, to rejection. Nonetheless, a special group of patients maintain stable graft function after complete withdrawal of immunosuppression, achieving a state called “operational …
- 210000001744 T-Lymphocytes 0 title abstract description 61
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Miura et al. | Association of Foxp3 regulatory gene expression with graft-versus-host disease | |
Bézie et al. | Ex vivo expanded human non-cytotoxic CD8+ CD45RClow/− Tregs efficiently delay skin graft rejection and GVHD in humanized mice | |
Arroyo Hornero et al. | CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells | |
Scumpia et al. | Increased natural CD4+ CD25+ regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsis | |
Wilson et al. | STAT3 is a critical cell-intrinsic regulator of human unconventional T cell numbers and function | |
Idris-Khodja et al. | Dual opposing roles of adaptive immunity in hypertension | |
Bigouret et al. | Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94: NKG2C/E and NKD2D killer cell receptors | |
Moraes-Vieira et al. | Differential monocyte STAT6 activation and CD4+ CD25+ Foxp3+ T cells in kidney operational tolerance transplanted individuals | |
Chu et al. | In vivo anti-inflammatory activities of novel cytokine IL-38 in Murphy Roths Large (MRL)/lpr mice | |
Chan et al. | NK cells produce high levels of IL‐10 early after allogeneic stem cell transplantation and suppress development of acute GVHD | |
Sgouroudis et al. | Impact of protective IL-2 allelic variants on CD4+ Foxp3+ regulatory T cell function in situ and resistance to autoimmune diabetes in NOD mice | |
Inui et al. | Human CD43+ B cells are closely related not only to memory B cells phenotypically but also to plasmablasts developmentally in healthy individuals | |
Yabe et al. | Cytotoxic Tph-like cells are involved in persistent tissue damage in IgG4-related disease | |
Meryk et al. | Fcμ receptor as a Costimulatory Molecule for T Cells | |
Ajith et al. | HLA-G dimer targets Granzyme B pathway to prolong human renal allograft survival | |
Assadiasl et al. | Regulatory T cell subtypes and TGF-β1 gene expression in chronic allograft dysfunction | |
Li et al. | Upregulated TRAIL and reduced DcR2 mediate apoptosis of decidual PMN-MDSC in unexplained recurrent pregnancy loss | |
Zhu et al. | Defective circulating CD4+ LAP+ regulatory T cells in patients with dilated cardiomyopathy | |
Mensink et al. | Tregs from human blood differentiate into nonlymphoid tissue–resident effector cells upon TNFR2 costimulation | |
Barcia Durán et al. | Immune checkpoint landscape of human atherosclerosis and influence of cardiometabolic factors | |
Oishi et al. | CD4− CD8− T cells bearing invariant V α 24J α Q TCR α-chain are decreased in patients with atopic diseases | |
García-Salum et al. | Molecular signatures associated with tumor-specific immune response in melanoma patients treated with dendritic cell-based immunotherapy | |
Litjens et al. | Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 | |
Lambert et al. | IL-6-driven pSTAT1 response is linked to T cell features implicated in early immune dysregulation | |
Kiaf et al. | Gata3 is detrimental to regulatory T cell function in autoimmune diabetes |